TrialCancer2017
A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma.
Stephen L Chan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled ittrialcites it